161 related articles for article (PubMed ID: 12656897)
1. Differences in biopsy features between prostate cancers located in the transition and peripheral zone.
Augustin H; Erbersdobler A; Graefen M; Jaekel T; Haese A; Huland H; Hammerer PG
BJU Int; 2003 Apr; 91(6):477-81. PubMed ID: 12656897
[TBL] [Abstract][Full Text] [Related]
2. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.
Sakai I; Harada K; Kurahashi T; Yamanaka K; Hara I; Miyake H
Int J Urol; 2006 Apr; 13(4):368-72. PubMed ID: 16734852
[TBL] [Abstract][Full Text] [Related]
3. Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol.
Durkan GC; Sheikh N; Johnson P; Hildreth AJ; Greene DR
BJU Int; 2002 Jan; 89(1):33-9. PubMed ID: 11849157
[TBL] [Abstract][Full Text] [Related]
4. Significance of routine transition zone biopsies in Japanese men undergoing transrectal ultrasound-guided prostate biopsies.
Miyake H; Kurahashi T; Muramaki M; Yamanak K; Hara I
Int J Urol; 2005 Nov; 12(11):964-8. PubMed ID: 16351652
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of prostate cancer originating from the transition zone.
King CR; Ferrari M; Brooks JD
Urol Oncol; 2009; 27(6):592-7. PubMed ID: 18799332
[TBL] [Abstract][Full Text] [Related]
6. Transition zone biopsy and prediction of extraprostatic extension at radical prostatectomy.
Onder AU; Yaycioglu O; Ataus S; Gul U; Demirkesen O; Yalcin V; Solok V
Int J Urol; 2003 Jun; 10(6):302-6; discussion 307-8. PubMed ID: 12757598
[TBL] [Abstract][Full Text] [Related]
7. Transition zone biopsy in the detection of prostate cancer.
Kojima Y; Nonomura N; Nose T; Inoue T; Tsuda K; Narumi Y; Nakamura H; Shin M; Yasunaga Y; Aozasa K; Miki T; Okuyama A
Eur Urol; 2000 Jun; 37(6):675-9. PubMed ID: 10828667
[TBL] [Abstract][Full Text] [Related]
8. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening project.
Pelzer AE; Bektic J; Berger AP; Halpern EJ; Koppelstätter F; Klauser A; Rehder P; Horninger W; Bartsch G; Frauscher F
Eur Urol; 2005 Dec; 48(6):916-21; discussion 921. PubMed ID: 16126324
[TBL] [Abstract][Full Text] [Related]
9. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
[TBL] [Abstract][Full Text] [Related]
10. Impact of transition zone biopsies in detection and evaluation of prostate cancer.
Onder AU; Yalcin V; Arar O; Yaycioglu O; Citci A; Solok V
Eur Urol; 1998; 33(6):542-8. PubMed ID: 9743695
[TBL] [Abstract][Full Text] [Related]
11. Does transurethral resection of the prostate facilitate detection of clinically significant prostate cancer that is missed with systematic sextant and transition zone biopsies?
Kitamura H; Masumori N; Tanuma Y; Yanase M; Itoh N; Takahashi A; Tsukamoto T; Adachi H; Hotta H
Int J Urol; 2002 Feb; 9(2):95-9. PubMed ID: 12028299
[TBL] [Abstract][Full Text] [Related]
12. Frequency and clinical significance of transition zone cancer in prostate cancer screening.
Reissigl A; Pointner J; Strasser H; Ennemoser O; Klocker H; Bartsch G
Prostate; 1997 Feb; 30(2):130-5. PubMed ID: 9051151
[TBL] [Abstract][Full Text] [Related]
13. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of systematic sextant transition zone biopsies in large prostates for cancer detection.
Chang JJ; Shinohara K; Hovey RM; Montgomery C; Presti JC
Urology; 1998 Jul; 52(1):89-93. PubMed ID: 9671876
[TBL] [Abstract][Full Text] [Related]
15. Critical evaluation of the current indications for transition zone biopsies.
Liu IJ; Macy M; Lai YH; Terris MK
Urology; 2001 Jun; 57(6):1117-20. PubMed ID: 11377321
[TBL] [Abstract][Full Text] [Related]
16. Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence.
O'Neil LM; Walsh S; Cohen RJ; Lee S
BJU Int; 2015 Oct; 116 Suppl 3():42-8. PubMed ID: 26218868
[TBL] [Abstract][Full Text] [Related]
17. Should transition zone biopsies be added to 12-core systematic biopsies of the prostate?
Hwang SI; Lee HJ; Cho JY; Kim SH; Lee SE; Byun SS; Hong SK; Choe GY
J Clin Ultrasound; 2009 Jun; 37(5):281-4. PubMed ID: 19309725
[TBL] [Abstract][Full Text] [Related]
18. Pathological findings of radical prostatectomy specimens in Japanese men diagnosed on single core positive prostate biopsy in eight with a Gleason score less than 4.
Miyake H; Ono Y; Park SJ; Hara I; Eto H
Int J Urol; 2003 Jul; 10(7):383-6. PubMed ID: 12823693
[TBL] [Abstract][Full Text] [Related]
19. The value of multiple core biopsies for predicting the Gleason score of prostate cancer.
Egevad L; Norlén BJ; Norberg M
BJU Int; 2001 Nov; 88(7):716-21. PubMed ID: 11890242
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the biological features between prostate cancers arising in the transition and peripheral zones.
Sakai I; Harada K; Hara I; Eto H; Miyake H
BJU Int; 2005 Sep; 96(4):528-32. PubMed ID: 16104904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
